Safety and Efficacy Study of Intrasphincteric Autologous Myoblast Injection to Treat Stress Urinary Incontinence

NCT01355133 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Stress Urinary Incontinence

Interventions

BIOLOGICAL: Transurethral intrasphincteric autologous myoblast implantation

Sponsor

University Medical Centre Ljubljana

Collaborators

[object Object]